Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docetaxel in Patients With Metastatic Breast Cancer Who Have Been Heavily Pretreated, Including Prior Treatment With Paclitaxel or Docetaxel.

NCT02041351 is registered in ClinicalTrials.gov with Centro Universitario contra el Cáncer as lead sponsor.

NCT NCT02041351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02041351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docetaxel in Patients With Metastatic Breast Cancer Who Have Been Heavily Pretreated, Including Prior Treatment With Paclitaxel or Docetaxel.
Lead sponsor
Centro Universitario contra el Cáncer
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2013
Completion date
December 31, 2015
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer